EA201070271A1 - Пептиды для получения вакцины - Google Patents
Пептиды для получения вакциныInfo
- Publication number
- EA201070271A1 EA201070271A1 EA201070271A EA201070271A EA201070271A1 EA 201070271 A1 EA201070271 A1 EA 201070271A1 EA 201070271 A EA201070271 A EA 201070271A EA 201070271 A EA201070271 A EA 201070271A EA 201070271 A1 EA201070271 A1 EA 201070271A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- vaccine
- peptides
- receiving
- prevention
- treatment
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title 1
- 230000002265 prevention Effects 0.000 abstract 2
- 208000035533 House dust allergy Diseases 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0003—Invertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
- C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/16—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56977—HLA or MHC typing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Insects & Arthropods (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Botany (AREA)
- Rheumatology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
Abstract
Настоящее изобретение относится к композициям, содержащим пептиды, используемые для профилактики или лечения аллергии на клещей домашней пыли, а в частности к оптимальным комбинациям пептидов, используемых для профилактики или лечения указанной аллергии.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0715949A GB0715949D0 (en) | 2007-08-15 | 2007-08-15 | Peptide with improved solubility |
GB0716224A GB0716224D0 (en) | 2007-08-20 | 2007-08-20 | Peptides for vaccine |
GB0723337A GB0723337D0 (en) | 2007-11-28 | 2007-11-28 | Peptide with reduced dimer formation |
PCT/GB2008/002780 WO2009022156A2 (en) | 2007-08-15 | 2008-08-15 | Peptides for desensibilization against allergens |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201070271A1 true EA201070271A1 (ru) | 2010-12-30 |
EA023303B1 EA023303B1 (ru) | 2016-05-31 |
Family
ID=40134075
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201070271A EA023303B1 (ru) | 2007-08-15 | 2008-08-15 | Пептидная композиция для формирования толерантности к клещам домашней пыли и ее применение |
EA201070270A EA018110B1 (ru) | 2007-08-15 | 2008-08-15 | Пептиды с пониженным уровнем образования димеров |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201070270A EA018110B1 (ru) | 2007-08-15 | 2008-08-15 | Пептиды с пониженным уровнем образования димеров |
Country Status (24)
Country | Link |
---|---|
US (7) | US8652485B2 (ru) |
EP (4) | EP2083856B1 (ru) |
JP (3) | JP5697447B2 (ru) |
KR (1) | KR101699554B1 (ru) |
CN (2) | CN103272227B (ru) |
AT (1) | ATE482721T1 (ru) |
AU (1) | AU2008288283B2 (ru) |
BR (1) | BRPI0815395A2 (ru) |
CA (1) | CA2696563A1 (ru) |
CY (2) | CY1110981T1 (ru) |
DE (1) | DE602008002810D1 (ru) |
DK (2) | DK2083856T3 (ru) |
EA (2) | EA023303B1 (ru) |
ES (1) | ES2402956T3 (ru) |
HK (2) | HK1132194A1 (ru) |
HR (2) | HRP20100662T1 (ru) |
IL (1) | IL203943A (ru) |
MX (1) | MX2010001779A (ru) |
NZ (2) | NZ583361A (ru) |
PL (1) | PL2083856T3 (ru) |
PT (2) | PT2397154E (ru) |
SI (2) | SI2190473T1 (ru) |
WO (4) | WO2009022155A2 (ru) |
ZA (2) | ZA201001054B (ru) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0710529D0 (en) | 2007-06-01 | 2007-07-11 | Circassia Ltd | Vaccine |
CA2696563A1 (en) * | 2007-08-15 | 2009-02-19 | Circassia Limited | Peptides for vaccine |
DK2153841T4 (en) | 2008-08-15 | 2016-02-15 | Circassia Ltd | Vaccine comprising Amb a 1 peptides for use in the treatment of ambrosieallergi |
WO2010018384A1 (en) * | 2008-08-15 | 2010-02-18 | Circassia Limited | T-cell antigen peptide from allergen for stimulation of il-10 production |
GB0821806D0 (en) | 2008-11-28 | 2009-01-07 | Circassia Ltd | Compositions with reduced dimer formation |
CN103784952B (zh) | 2009-02-05 | 2016-08-17 | 切尔卡西亚有限公司 | 用于疫苗的草肽 |
JP5860402B2 (ja) * | 2009-10-08 | 2016-02-16 | イオン メディックス インコーポレイテッド | 室内空気由来細胞外ベシクルを含む組成物及びその用途 |
EP3170510A1 (de) * | 2010-01-14 | 2017-05-24 | Merck Patent GmbH | Varianten der gruppe 5-allergene der süssgräser mit reduzierter allergenität durch mutagenese von prolinresten |
GB201002559D0 (en) * | 2010-02-15 | 2010-03-31 | Circassia Ltd | Birch peptides for vaccine |
EP2575832B1 (en) * | 2010-06-03 | 2017-07-26 | ALK-Abelló A/S | Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof |
US20130259884A1 (en) * | 2010-09-24 | 2013-10-03 | Alergenetica Sl | Peptides |
EP2460824A1 (en) * | 2010-12-01 | 2012-06-06 | Biomay Ag | Hypoallergenic polypeptides for the treatment of house dust mite allergy |
US9289476B2 (en) | 2011-04-29 | 2016-03-22 | Selecta Biosciences, Inc. | Tolerogenic synthetic nanocarriers for allergy therapy |
CA2838888A1 (en) * | 2011-06-15 | 2012-12-20 | Biotech Tools S.A. | A method for the production of hydrolyzed allergens |
KR20140050698A (ko) | 2011-07-29 | 2014-04-29 | 셀렉타 바이오사이언시즈, 인크. | 체액성 및 세포독성 t 림프구(ctl) 면역 반응을 발생시키는 합성 나노운반체 |
GB201208293D0 (en) * | 2012-05-11 | 2012-06-20 | Circassia Ltd | Hydrochlorice salt of peptide |
GB201209868D0 (en) * | 2012-06-01 | 2012-07-18 | Circassia Ltd | Alternaria peptides |
GB201209862D0 (en) | 2012-06-01 | 2012-07-18 | Circassia Ltd | Cladosporium peptides |
CA2889784C (en) | 2012-10-30 | 2024-04-30 | Monash University | Novel immunotherapeutic molecules and uses thereof |
JP7028556B2 (ja) | 2013-05-03 | 2022-03-02 | セレクタ バイオサイエンシーズ インコーポレーテッド | 特定の薬力学的有効期間および免疫寛容の誘発のための抗原を有する免疫抑制剤の送達 |
EP3003365A1 (en) * | 2013-06-05 | 2016-04-13 | Maria R. Diaz-Torres | T cell epitopes derived from alt a 1 or alt a 5 for the treatment of alternaria alternata allergy |
ES2828448T3 (es) * | 2013-06-06 | 2021-05-26 | Anergis S A | Péptidos superpuestos contiguos para el tratamiento de la alergia a los ácaros del polvo doméstico |
AU2014328483B2 (en) | 2013-09-25 | 2019-11-14 | Aravax Pty Ltd | Novel immunotherapeutic composition and uses thereof |
MX2016008305A (es) * | 2013-12-23 | 2017-01-11 | Alk-Abelló As | Combinaciones de peptidos y usos de los mismos en tratar alergia al acaro del polvo. |
EA034692B1 (ru) | 2014-03-31 | 2020-03-06 | Бёрингер Ингельхайм Ветмедика Гмбх | Улучшенные транспортные молекулы модулярного антигена и их применение |
US10071114B2 (en) | 2014-09-07 | 2018-09-11 | Selecta Biosciences, Inc. | Methods and compositions for attenuating gene expression modulating anti-viral transfer vector immune responses |
US11452774B2 (en) | 2015-02-20 | 2022-09-27 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
US10143742B2 (en) | 2015-02-20 | 2018-12-04 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
US10149904B2 (en) | 2015-02-20 | 2018-12-11 | The Board Of Trusteees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
US10166286B2 (en) | 2015-02-20 | 2019-01-01 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
KR20170126001A (ko) * | 2015-03-30 | 2017-11-15 | 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 | 면역용 펩티드, 면역용 펩티드의 제조 방법, 그것을 포함하는 면역 질환용 의약 조성물, 및 면역 질환의 치료 방법 |
EP3355917A1 (en) | 2015-09-30 | 2018-08-08 | Boehringer Ingelheim Vetmedica GmbH | Improved modular antigen transportation molecules and uses therof in animals |
KR101858840B1 (ko) | 2016-01-15 | 2018-05-16 | 단국대학교 천안캠퍼스 산학협력단 | 집먼지진드기 유래 알레르겐에 의한 과민반응 면역조절제 |
US11426451B2 (en) | 2017-03-11 | 2022-08-30 | Selecta Biosciences, Inc. | Methods and compositions related to combined treatment with antiinflammatories and synthetic nanocarriers comprising an immunosuppressant |
CN111465328A (zh) | 2017-07-18 | 2020-07-28 | 前品牌股份有限公司 | 制备混合型变应原组合物的方法 |
WO2019055931A1 (en) * | 2017-09-18 | 2019-03-21 | Sutro Biopharma, Inc. | ALPHA ANTI-FOLATE ANTIBODY-RECEPTOR CONJUGATES AND USES THEREOF |
CN108078891B (zh) * | 2017-12-28 | 2021-05-07 | 昆明赛诺制药股份有限公司 | 一种含美洲大蠊精提物的保湿修复洗面奶 |
CN107970199B (zh) * | 2018-01-03 | 2021-05-07 | 昆明赛诺制药股份有限公司 | 一种含美洲大蠊精提物的牙膏 |
WO2020154476A1 (en) | 2019-01-23 | 2020-07-30 | Before Brands, Inc. | Methods for making mixed allergen compositions |
CN117362453B (zh) * | 2023-12-08 | 2024-02-27 | 山东硕景生物科技有限公司 | 一种Derf1重组抗原、其制备方法及应用 |
Family Cites Families (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3174456D1 (en) | 1980-07-18 | 1986-05-28 | Du Pont | Monothioglycerol as thiol-protector in lyophilized materials |
US4442212A (en) * | 1980-11-10 | 1984-04-10 | E. I. Du Pont De Nemours & Company | Monothioglycerol as thiol-protector in lyophilized materials |
US5126399A (en) | 1986-04-30 | 1992-06-30 | Board Of Regents, The University Of Texas System | Methods and compositions for the preparation and use of site-directed immunologic reagents |
US4906564A (en) | 1987-03-13 | 1990-03-06 | The United States Of America As Represented By The Secretary Of The Army | Antigenic determinants recognized by antibodies obtained using a pathogenic agent or a derivative thereof that presents a restricted set of antigens |
EP0765936A1 (en) * | 1987-06-17 | 1997-04-02 | Institute For Child Health Research | Cloning of mite allergens |
FI891226A (fi) | 1988-04-28 | 1989-10-29 | Univ Leland Stanford Junior | Reseptordeterminanter i anti-t-celler foer behandling av autoimmunsjukdom. |
GB8812214D0 (en) | 1988-05-24 | 1988-06-29 | Hoffmann La Roche | Use of peptide from circumsporozoite protein of p falciparum as universally recognized t-cell epitope |
ES2013359A6 (es) | 1988-11-04 | 1990-05-01 | Corporacion Biolog Farmaceutic | Procedimiento para la fabricacion de alergenos inmunogenicos polimerizados. |
CA1340977C (en) | 1988-11-15 | 2000-04-25 | Monty Krieger | Scavenger receptor protein and antibody thereto |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
US6019972A (en) * | 1989-11-03 | 2000-02-01 | Immulogic Pharmaceutical Corporation | Peptides of human T cell reactive feline protein (TRFP) |
CA2073045C (en) | 1989-11-03 | 2007-05-22 | Malcolm L. Gefter | A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor |
US5547669A (en) | 1989-11-03 | 1996-08-20 | Immulogic Pharma Corp | Recombinant peptides comprising T cell epitopes of the cat allergen, Fel d I |
US5433948A (en) * | 1990-02-13 | 1995-07-18 | Thomas; Wayne R. | Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
AU655599B2 (en) | 1990-09-11 | 1995-01-05 | Institute For Child Health Research | Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
US5593698A (en) | 1990-10-31 | 1997-01-14 | Autoimmune, Inc. | Suppression of proliferative response and induction of tolerance with polymorphic class II MHC allopeptides |
JP2632603B2 (ja) | 1991-03-12 | 1997-07-23 | アサヒビール株式会社 | ヒト抗DerfIIIgE抗体が結合するペプチド |
US6982326B1 (en) * | 1991-07-12 | 2006-01-03 | Immulogic Pharmaceutical Corporation | Allergenic proteins and peptides from Japanese cedar pollen |
US6555116B1 (en) | 1991-10-12 | 2003-04-29 | Regents Of The University Of California | Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin |
EP0623168B1 (en) * | 1991-10-16 | 2009-09-30 | Merck Patent GmbH | T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
US7288256B1 (en) * | 1991-10-16 | 2007-10-30 | Merck Patent Gmbh | T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
WO1994024281A1 (en) | 1993-04-14 | 1994-10-27 | Immulogic Pharmaceutical Corporation | T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
US6696061B1 (en) * | 1992-08-11 | 2004-02-24 | President And Fellows Of Harvard College | Immunomodulatory peptides |
US5460977A (en) | 1992-08-14 | 1995-10-24 | Torii & Co. | Peptide having allergenicity |
EP1277764A3 (en) * | 1992-12-31 | 2003-01-29 | Immulogic Pharmaceutical Corporation | Allergenic proteins and peptides from dog dander and uses therefor |
US5697103A (en) | 1993-01-11 | 1997-12-16 | Personal Expression I, Inc. | Therapeutic glove |
WO1994021675A2 (en) | 1993-03-12 | 1994-09-29 | Immulogic Pharmaceutical Corporation | T cell epitopes of ryegrass pollen allergen |
US6849427B1 (en) * | 1993-03-12 | 2005-02-01 | Immulogic Pharmaceutical Corp. | Nucleic acids encoding a house dust mite allergen, Der p VII, and uses therefor |
KR960701995A (ko) * | 1993-04-14 | 1996-03-28 | 스테이시 엘. 채닝 | 더마토파고이드즈(집 먼지 진드기)로부터의 주요 알레르겐의 t세포 에피토프(t.cells epitopes of the major allergens from dermatophagoids(house dust mite)) |
EP0705108A4 (en) | 1993-06-02 | 1997-08-06 | Tvw Telethon Inst Child Health | USE OF CRYPTIC PEPTIDES FOR INDUCTION IMMUNOLOGICAL TOLERANCE |
WO1995006728A2 (en) | 1993-08-13 | 1995-03-09 | Immulogic Pharmaceutical Corporation | T cell epitopes of ryegrass pollen allergen |
US6180771B1 (en) * | 1993-12-08 | 2001-01-30 | Immulogic Pharmaceutical Corp. | Nucleic acids encoding a house dust mite allergen, Der p III, and uses therefor |
JPH07215996A (ja) | 1994-01-31 | 1995-08-15 | Torii Yakuhin Kk | ダニアレルゲンのb細胞エピトープ |
JPH09512014A (ja) * | 1994-04-14 | 1997-12-02 | イミユロジク・フアーマシユーチカル・コーポレーシヨン | ダニアレルギー治療用の医薬ペプチド組成物 |
US5820862A (en) * | 1994-04-14 | 1998-10-13 | Immulogic Pharmaceutical Corporation | T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
US6759234B1 (en) * | 1994-09-02 | 2004-07-06 | Immulogic Pharmaceutical Corporation | Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response |
IL115744A (en) | 1994-10-27 | 2000-07-16 | Akzo Nobel Nv | Peptides comprising a subsequence of human cartilage glycoprotein - 39 |
DE19508192A1 (de) * | 1995-03-09 | 1996-09-12 | Behringwerke Ag | Stabile Transglutaminasepräparate und Verfahren zu ihrer Herstellung |
DE19545662C2 (de) * | 1995-12-07 | 1998-11-26 | Mannesmann Sachs Ag | Selbstpumpendes hydropneumatisches Federbein mit innerer Niveauregulierung |
EP0888541B1 (en) | 1996-03-21 | 2005-05-25 | Circassia Limited | Cryptic peptides and method for their identification |
CA2316015A1 (en) | 1997-12-22 | 1999-07-01 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 formulations |
WO1999034826A1 (en) | 1998-01-09 | 1999-07-15 | Circassia Limited | Methods and compositions for desensitisation |
FR2806727A1 (fr) * | 2000-03-23 | 2001-09-28 | Pf Medicament | Molecule d'interet pharmaceutique comprotant en son extremite n-terminale un acide glutamique ou une glutamine sous forme de sel d'addition d'acide fort physiologiquement acceptable |
KR20030062321A (ko) | 2000-08-21 | 2003-07-23 | 아피토프 테크놀러지 (브리스톨) 리미티드 | 펩티드 선별 방법 |
WO2002017956A2 (en) * | 2000-08-31 | 2002-03-07 | Chiron Corporation | Stabilized fgf formulations containing reducing agents |
EP1373510B1 (en) * | 2000-11-16 | 2008-11-19 | Alk-Abello A/S | Mutant allergens |
US7786257B2 (en) * | 2000-12-18 | 2010-08-31 | University Of Kansas | Signal-1/signal-2 bifunctional peptide inhibitors |
US7264810B2 (en) | 2001-01-19 | 2007-09-04 | Cytos Biotechnology Ag | Molecular antigen array |
FR2820425B1 (fr) | 2001-02-08 | 2004-01-02 | Commissariat Energie Atomique | Melange de peptides issus d'une proteine nef et leurs applications |
JP4812951B2 (ja) | 2001-03-21 | 2011-11-09 | 一般財団法人化学及血清療法研究所 | 特異性不明のt細胞のクローン化法及びその認識ペプチドリガンドの同定方法 |
GB0108752D0 (en) | 2001-04-06 | 2001-05-30 | Isis Innovation | Peptide epitopes and uses thereof |
US20040202654A1 (en) | 2001-04-09 | 2004-10-14 | Mayo Foundation For Medical Education & Research | Methods and materials for cancer treatment |
AUPR775401A0 (en) | 2001-09-18 | 2001-10-11 | Monash University | Novel Epitopes and Uses Thereof |
DK1450847T3 (da) | 2001-11-13 | 2010-12-13 | Genentech Inc | Apo2-ligand/TRAIL-formuleringer og anvendelser deraf |
JP4874522B2 (ja) * | 2001-12-05 | 2012-02-15 | サーカッシア リミテッド | 免疫療法および系 |
AUPS148202A0 (en) | 2002-04-02 | 2002-05-09 | Monash University | Immunotherapeutic and immunoprophylactic reagents |
FR2841906B1 (fr) | 2002-07-05 | 2006-08-18 | Stallergenes Sa | Molecule d'acide nucleique codant une preproproteine d'allergene d'un acarien du genre dermatophagoides ou euroglyphus et son utilisation pour la production dudit allergene dans les plantes |
BR0312935A (pt) | 2002-07-17 | 2005-06-21 | Cytos Biotechnology Ag | Partìcula semelhante a vìrus, muteìna, vetores para produzir a referida partìcula e proteìna recombinante, composição, processo para produção de fileira ordena e repetitva de antìgeno, molécula de ácido nucléico, célula hospedeira, método para produção da referida partìcula e uso da composição de vacina |
US20040071718A1 (en) | 2002-09-18 | 2004-04-15 | Jaw-Ji Tsai | Local nasal immunotherapy for allergen-induced airway inflammation |
AU2004216925B2 (en) | 2003-03-07 | 2010-04-22 | London Health Sciences Centre Research Inc. | Peptides associated with HLA-DR MHC class II molecules involved in autoimmune diseases |
ATE368687T1 (de) | 2003-06-26 | 2007-08-15 | Merck Patent Gmbh | Thrombopoietinproteine mit verbesserten eigenschaften |
GB0315754D0 (en) * | 2003-07-04 | 2003-08-13 | Univ Aberdeen | Pharmaceutical compositions |
US20050053615A1 (en) * | 2003-07-16 | 2005-03-10 | Best Elaine A. | Variants of mite group 1 allergens for the treatment of house dust mite allergy |
AU2004288854B2 (en) | 2003-11-10 | 2009-10-01 | Arriva-Pharmaceuticals, Inc. | Dry recombinant human alpha 1-antitrypsin formulation |
WO2005103082A2 (en) | 2004-04-23 | 2005-11-03 | Novozymes A/S | Group 1 mite polypeptide variants |
WO2005121166A1 (en) | 2004-06-10 | 2005-12-22 | Monash University | Novel immunointeractive molecules and uses thereof |
US20060029551A1 (en) | 2004-08-05 | 2006-02-09 | Kui Liu | Stable particle formulations of erythropoietin receptor agonists |
US7732426B2 (en) * | 2004-09-27 | 2010-06-08 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Isocyclomaltooligosaccharide (S) , isocyclomaltooligosaccharide-forming enzyme, their preparation and uses |
EP1843779A2 (en) | 2005-02-01 | 2007-10-17 | Attenuon, LLC | Compositions containing the anti-angiogenic phscn-peptide |
FR2881746B1 (fr) | 2005-02-07 | 2007-04-13 | Centre Nat Rech Scient | Epitopes t cd4+des antigenes de latence de type i et ii du virus epstein-barr aptes a etre reconnus par la majorite des individus de la population caucasienne et leurs applications |
AU2006291835B2 (en) | 2005-09-15 | 2012-04-05 | Alk-Abello A/S | A method for quantification of allergens |
EP1829895A1 (en) | 2006-03-03 | 2007-09-05 | f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. | Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies |
GB0609121D0 (en) | 2006-05-09 | 2006-06-21 | Univ Birmingham | Peptide Therapy |
AT503690A1 (de) | 2006-06-09 | 2007-12-15 | Biomay Ag | Hypoallergene moleküle |
PL2059256T3 (pl) * | 2006-08-11 | 2017-02-28 | Life Sciences Research Partners Vzw | Immunogenne peptydy i ich zastosowanie w zaburzeniach immunologicznych |
EP1958645A1 (en) | 2007-02-13 | 2008-08-20 | Biomay AG | Peptides derived from the major allergen of ragweed (Ambrosia artemisiifolia) and uses thereof |
US8148105B2 (en) | 2007-03-16 | 2012-04-03 | The Board Of Trustees Of The Leland Stanford Junior University | Scaleable manufacturing process for cysteine endoprotease B, isoform 2 |
GB0710529D0 (en) * | 2007-06-01 | 2007-07-11 | Circassia Ltd | Vaccine |
CA2696563A1 (en) | 2007-08-15 | 2009-02-19 | Circassia Limited | Peptides for vaccine |
WO2009067191A2 (en) * | 2007-11-16 | 2009-05-28 | The General Hospital Corporation | Methods and compositions for the treatment of hepatitis c virus (hcv) infection |
GB2455108A (en) | 2007-11-28 | 2009-06-03 | Circassia Ltd | T-Cell dependent method for detecting non-allergic or intrinsic disorders |
-
2008
- 2008-08-15 CA CA2696563A patent/CA2696563A1/en not_active Abandoned
- 2008-08-15 PT PT111781811T patent/PT2397154E/pt unknown
- 2008-08-15 SI SI200830933T patent/SI2190473T1/sl unknown
- 2008-08-15 ES ES08788347T patent/ES2402956T3/es active Active
- 2008-08-15 DK DK08788348.4T patent/DK2083856T3/da active
- 2008-08-15 MX MX2010001779A patent/MX2010001779A/es active IP Right Grant
- 2008-08-15 EA EA201070271A patent/EA023303B1/ru not_active IP Right Cessation
- 2008-08-15 BR BRPI0815395-7A2A patent/BRPI0815395A2/pt not_active IP Right Cessation
- 2008-08-15 WO PCT/GB2008/002779 patent/WO2009022155A2/en active Application Filing
- 2008-08-15 CN CN201310140326.XA patent/CN103272227B/zh not_active Expired - Fee Related
- 2008-08-15 EP EP08788348A patent/EP2083856B1/en active Active
- 2008-08-15 DE DE602008002810T patent/DE602008002810D1/de active Active
- 2008-08-15 EP EP10006685A patent/EP2286833A3/en not_active Withdrawn
- 2008-08-15 AT AT08788348T patent/ATE482721T1/de active
- 2008-08-15 US US12/673,412 patent/US8652485B2/en active Active
- 2008-08-15 US US12/673,386 patent/US9340580B2/en not_active Expired - Fee Related
- 2008-08-15 NZ NZ583361A patent/NZ583361A/xx not_active IP Right Cessation
- 2008-08-15 WO PCT/GB2008/002780 patent/WO2009022156A2/en active Application Filing
- 2008-08-15 WO PCT/GB2008/002781 patent/WO2009022157A2/en active Application Filing
- 2008-08-15 WO PCT/GB2008/002778 patent/WO2009022154A2/en active Application Filing
- 2008-08-15 EA EA201070270A patent/EA018110B1/ru not_active IP Right Cessation
- 2008-08-15 KR KR1020107005503A patent/KR101699554B1/ko active IP Right Grant
- 2008-08-15 PL PL08788348T patent/PL2083856T3/pl unknown
- 2008-08-15 PT PT08788348T patent/PT2083856E/pt unknown
- 2008-08-15 EP EP08788347A patent/EP2190473B1/en not_active Revoked
- 2008-08-15 EP EP11178181.1A patent/EP2397154B1/en active Active
- 2008-08-15 JP JP2010520628A patent/JP5697447B2/ja not_active Expired - Fee Related
- 2008-08-15 NZ NZ583362A patent/NZ583362A/en not_active IP Right Cessation
- 2008-08-15 AU AU2008288283A patent/AU2008288283B2/en not_active Ceased
- 2008-08-15 US US12/673,334 patent/US8551493B2/en active Active
- 2008-08-15 SI SI200830119T patent/SI2083856T1/sl unknown
- 2008-08-15 CN CN2008801116120A patent/CN101820907B/zh not_active Expired - Fee Related
- 2008-08-15 DK DK08788347.6T patent/DK2190473T3/da active
-
2009
- 2009-12-24 HK HK09112173.5A patent/HK1132194A1/xx not_active IP Right Cessation
-
2010
- 2010-02-12 ZA ZA2010/01054A patent/ZA201001054B/en unknown
- 2010-02-12 ZA ZA2010/01056A patent/ZA201001056B/en unknown
- 2010-02-14 IL IL203943A patent/IL203943A/en not_active IP Right Cessation
- 2010-12-01 HR HR20100662T patent/HRP20100662T1/hr unknown
- 2010-12-07 CY CY20101101127T patent/CY1110981T1/el unknown
-
2012
- 2012-06-01 HK HK12105353.6A patent/HK1164700A1/xx not_active IP Right Cessation
-
2013
- 2013-03-25 HR HRP20130270AT patent/HRP20130270T1/hr unknown
- 2013-08-23 US US13/974,603 patent/US20130336999A1/en not_active Abandoned
-
2014
- 2014-01-08 US US14/150,045 patent/US20140186403A1/en not_active Abandoned
- 2014-10-03 JP JP2014204979A patent/JP6040207B2/ja not_active Expired - Fee Related
-
2015
- 2015-10-07 CY CY20151100901T patent/CY1116828T1/el unknown
-
2016
- 2016-04-11 US US15/095,480 patent/US20160289281A1/en not_active Abandoned
- 2016-09-29 JP JP2016191563A patent/JP2017061455A/ja active Pending
- 2016-10-17 US US15/294,973 patent/US9744222B2/en active Active - Reinstated
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201070271A1 (ru) | Пептиды для получения вакцины | |
DE602008002693D1 (de) | Vakzine-peptid-kombinationen gegen katzenallergie | |
EA201000844A1 (ru) | Связывающие wise агенты и эпитопы | |
EA201001491A1 (ru) | Репликационно-дефектные вакцины и вакцинные векторы против флавивирусов | |
MA33803B1 (fr) | Inhibiteur de bromodomaine de benzodiazépine | |
BR112012014082A2 (pt) | composições e métodos que compreendem variantes de protease | |
EA201000777A1 (ru) | Ингибиторы репликации вируса иммунодефицита человека | |
MX2012007098A (es) | Derivados fenolicos y su uso farmaceutico o cosmetico. | |
EA201200550A1 (ru) | Фармацевтические композиции, включающие bi-1356 и метформин | |
UA94221C2 (en) | Lipocalin protein | |
MX2012007161A (es) | Derivados fenolicos y su uso farmaceutico o cosmetico. | |
EA200701825A1 (ru) | Вакцины против хламидиоза | |
MA33208B1 (fr) | Anticorps anti-fgfr3 et procédés d'utilisation de ceux-ci | |
EA201000950A1 (ru) | Азолилметилоксираны, их применение, а также содержащие их средства | |
EA201171001A1 (ru) | Пептиды трав для вакцины | |
EA201070219A1 (ru) | Полимерные мультиэпитопные вакцины против гриппа | |
EA201270313A1 (ru) | Композиции, которые индуцируют хелперное действие т-клеток | |
BRPI1015043A2 (pt) | derivados de diazahomoadamantano e métodos de uso dos mesmos | |
UA108636C2 (xx) | Пептид | |
EA201290792A1 (ru) | Пептиды для вакцины против аллергии на березу | |
MY157782A (en) | Compositions and methods for the treatment of xerostomia | |
MY155410A (en) | Compositions and devices | |
MA32321B1 (fr) | Pregn-4-en-21, 17 carbolactones substitués sur le noyau c, et préparations pharmaceutiques contenant ces derniers | |
EA201171414A1 (ru) | Ингибиторы белков семейства iap | |
MX2009007929A (es) | Uso de un primer alergeno del grupo 2 de acaro de polvo de casa para tratar alergia a un segundo alergeno del grupo 2 de acaro de polvo de casa. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |